Microbiome Sequencing Outsourcing Services Market (By Application: Shotgun Sequencing; Laboratory Type: Wet Labs; By End-Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Industry Insights

The global microbiome sequencing outsourcing services market is expected to register significant growth over the forecast period. Microbiomes are microorganisms living in the human body. They live on the eyes, skin, saliva, gastrointestinal tract, and mouth. Disruption of these microbes can lead to severe diseases. The key factors driving the microbiome sequencing outsourcing services market include technological advancements in next-generation sequencing, and the rising use of microbiome in genomics, proteomics, and metabolomics. Increasing outsourcing services by companies due to investments in R&D activities is also a key factor propelling the growth of the market. Microbiome sequencing is generally done to comprehend the microflora residing in the human body to understand human microbes and their part in related disorders. Hence, the industry is widely propelled by research-based communities, particularly in developed countries such as the U.K. and U.S.

However, the COVID-19 pandemic has resulted in a positive impact on the microbiome sequencing outsourcing services market. Typically, cancer and pathology are the two disciplines where microbiome sequencing is most prevalent. RNA sequencing has the potential to establish both the presence of the virus and define the host’s response to COVID-19. Hence, the growing usage of microbiome sequencing tools during the COVID-19 pandemic is one of the major factors supporting its growth in 2020 and across.

Based on application, shotgun sequencing is estimated to register the fastest growth during the forecast period due to faster results and low cost than other methods requiring a genetic gap. Furthermore, it is used to remove errors, fill in gaps, or repair sections of the sequence that were initially built improperly.

The Asia Pacific region is expected to register the fastest CAGR over the forecast period due to the rising prevalence of diseases like cancer, diabetes, and obesity which are related to the human microbiome. The increase in the research activities related to microbiome sequencing and rising government support in the region is the primary factor propelling the microbiome sequencing outsourcing services market growth.

Key Players

• Clinical-Microbiomics
• Zymo Research Corp.
• Microbiome Therapeutics, LLC.
• Microbiome Insights Inc.
• MR DNA (Molecular Research Lp)
• MerieuxNutrisciences Corporation
• Metabiomics Corp.
• Rancho Biosciences
• others